Company intelligence / Profile preview
Beijing Health Guard Biotechnology Inc.
- Ownership
- Private
- Development stage
- Other
Overview
Beijing Health Guard Biotechnology has a robust pipeline of prophylactic and therapeutic vaccines, with its most advanced product being a trivalent HPV vaccine expected to seek Chinese marketing approval by the end of this year. The company also has a nine-valent HPV vaccine in late-stage development, including clinical trials for men—the first such effort by a Chinese company. Additional programs include an mRNA-based HPV vaccine and preclinical candidates targeting RSV, VZV, hand-foot-and-mouth disease, norovirus, and COVID‑19. No products have been approved or commercialized as of May 2025[1][5][7].
- Therapeutic areas
- Women's HealthInfectious Diseases
- Modalities
- Recombinant protein vaccines (including E. coli-expressed)mRNA vaccines
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Beijing Health Guard Biotechnology Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing Health Guard Biotechnology Inc..